BD1.AX - BARD1 Life Sciences Limited

ASX - ASX Delayed price. Currency in AUD
Currency in AUD

Valuation measures

Market cap (intra-day) 524.86M
Enterprise value 321.15M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)93.93
Price/book (mrq)8.33
Enterprise value/revenue 379.90
Enterprise value/EBITDA 6N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun. 2018
Most-recent quarter (mrq)31 Dec. 2018

Profitability

Profit margin 0.00%
Operating margin (ttm)-718.89%

Management effectiveness

Return on assets (ttm)-47.68%
Return on equity (ttm)-89.92%

Income statement

Revenue (ttm)264.68k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-4.60%
Gross profit (ttm)-685.7k
EBITDA N/A
Net income avi to common (ttm)-1.92M
Diluted EPS (ttm)-0.0030
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.71M
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)10.14
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-1.82M
Levered free cash flow (ttm)-1.12M

Trading information

Stock price history

Beta (3Y monthly) -7.53
52-week change 370.42%
S&P500 52-week change 34.25%
52-week high 30.0734
52-week low 30.0098
50-day moving average 30.0195
200-day moving average 30.0198

Share statistics

Avg vol (3-month) 35.4M
Avg vol (10-day) 38.81M
Shares outstanding 5994.4M
Float 689.65M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor (new per old) 210/1
Last split date 311 Sep. 2008